IFIH1 and COVID-19: Third, we observed that the SARS-CoV-2 M protein specifically inhibits RIG-I/MDA-5–MAVS signaling rather than TLR3–TRIF or cGAS–STING signaling, a finding that may suggest more precise therapeutic targets for COVID-19.